Sam Rubinstein, MD is a clinical fellow in the division of Hematology and Oncology. He started as a postdoctoral fellow in the department of biomedical informatics in June 2018. His primary interests are in identification of biomarkers for patients with plasma cell dyscrasias and in exploring ways that evidence-based practices can be better-integrated into oncology practice. He is eager to learn how to leverage Vanderbilt’s unique institutional resources, including BioVU and the PheWAS catalog, to generate hypotheses that are relevant to the personalized treatment of patients with plasma cell disorders.
2006-2010: B.A., Economics, Northwestern University
2010-2014: M.D., University of Illinois at Chicago
2014-2015: Internship, Internal Medicine, Vanderbilt University Medical Center
2015-2017: Residency, Internal Medicine, Vanderbilt University Medical Center
2017-Present: Fellowship, Hematology and Oncology, Vanderbilt University Medical Center
2018-Present: Postdoctoral Fellow, Vanderbilt Genomic Medicine Training Program